April 25, 2017
Wilson Therapeutics presents promising neurological Phase 2 data for WTX101 at AAN meeting
Media
April 25, 2017
Targovax ASA: First quarter 2017 results
April 24, 2017
Aarhus University Hospital in Denmark Purchases NBS System from Nexstim Plc
April 24, 2017
Wilson Therapeutics presented positive final Phase 2 data for WTX101 at EASL Annual Meeting
April 24, 2017
Clinigen and Onxeo initiate Managed Access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL)
April 24, 2017
Capio acquires a Swedish eye specialist clinic in Stockholm
April 20, 2017
Onxeo receives the EnterNext Tech 40 Label
April 20, 2017
Cash position and update on clinical developments for Q1 2017
April 20, 2017
GenSight Biologics to Present GS010 at the 2017 Annual Meeting of the American Association of Neurology
April 20, 2017
Targovax initiates first clinical trial with TG02, the second product from its RAS-peptide immunotherapy platform
